Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Jun 27, 2022; 14(6): 556-566
Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.556
Table 3 Clinical symptoms and vital signs at presentation
Signs at presentation
Overall, n = 148
Viable bowel, n = 28
Reversible ischemia, n = 82
Irreversible ischemia, n = 34
P value
Vomiting, n (%)0.07
No36 (24.32)9 (32.14)15 (17.44)12 (35.29)
Yes112 (75.68)19 (67.86)71 (82.56)22 (64.71)
Obstipation1, n (%)0.60
No105 (70.95)22 (78.57)60 (69.77)23 (67.65)
Yes43 (29.05)6 (21.43)26 (30.23)11 (32.35)
Abdominal guarding, n (%)0.35
No133 (89.86)27 (96.43)77 (89.53)29 (85.29)
Yes15 (10.14)1 (3.57)9 (10.47)5 (14.71)
Heart rate2, n (%)0.42
Bradycardia2 (1.35)0 (0.00)1 (1.16)1 (2.94)
Normocardia120 (81.08)26 (92.86)67 (77.91)27 (79.41)
Tachycardia26 (17.67)2 (7.14)18 (20.93)6 (17.65)
Respiratory rate3,4, n (%)0.50
Normopnoea45 (60.00)9 (69.23)27 (64.29)9 (45.00)
Tachypnea30 (40.00)4 (30.77)15 (35.71)11 (55.00)
Fever5, n (%)0.52
No138 (97.18)25 (96.15)79 (96.34)34 (100.00)
Yes4 (2.82)1 (3.85)3 (3.66)0 (0.00)